Funding Rounds
Immunocore Series C (2021, $75M)
ImmunocoreBiotechnology company develops TCR bispecific immunotherapies.
Summary
Stage: Series C
Raised Amount: $75.00M
Raised Date: 2021-01-01
Stage: Series C
Raised Amount: $75.00M
Raised Date: 2021-01-01